Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer
Clinical trial NCT06776757 · RECRUITING
Trial details
- NCT number
- NCT06776757
- Sponsor
- Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-25
- Primary completion
- 2025-06-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.